Bulletin 371 launched - Polypharmacy and deprescribing

Our Polypharmacy and deprescribing update considers national and international resources that help support the understanding of polypharmacy and safe deprescribing, the evidence base for deprescribing and the impact of frailty and multimorbidity on polypharmacy.

View >